DXN Holdings Bhd. (KLSE:DXN)
Malaysia · Delayed Price · Currency is MYR 0.4950
-0.0050 (-1.00%)
At close: Feb 6, 2026
DXN Holdings Bhd. Revenue
DXN Holdings Bhd. had revenue of 474.86M MYR in the quarter ending November 30, 2025, a decrease of -3.87%. This brings the company's revenue in the last twelve months to 1.91B, down -1.59% year-over-year. In the fiscal year ending February 28, 2025, DXN Holdings Bhd. had annual revenue of 1.94B with 6.39% growth.
Revenue (ttm)
1.91B
Revenue Growth
-1.59%
P/S Ratio
1.29
Revenue / Employee
548.81K
Employees
3,489
Market Cap
2.46B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Feb 28, 2025 | 1.94B | 116.28M | 6.39% |
| Feb 29, 2024 | 1.82B | 203.21M | 12.56% |
| Feb 28, 2023 | 1.62B | 354.43M | 28.06% |
| Feb 28, 2022 | 1.26B | 196.16M | 18.39% |
| Feb 28, 2021 | 1.07B | -56.91M | -5.06% |
| Feb 29, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2011 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2010 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2009 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Duopharma Biotech Berhad | 900.68M |
| Y.S.P. Southeast Asia Holding Berhad | 367.14M |
| Kotra Industries Berhad | 223.64M |
| Rhone Ma Holdings Berhad | 211.93M |
| PeterLabs Holdings Berhad | 152.65M |
| Sunzen Group Berhad | 77.29M |
| Nova Wellness Group Berhad | 45.99M |
| Bioalpha Holdings Berhad | 5.14M |